삼성서울병원

Ko En

Hematology-Oncology Park, Se Hoon M.D

Expertise
Chemotherapy and clinical trials in gastrointestinal and genitourinary cancers
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

Konkuk University College of Medicine, Seoul, Korea

Post-Graduate Training

Fellowship   Division of Hematology/Oncology, Department of Medicine, Samsung Medical Center, Seoul, Korea
Residency   Samsung Medical Center, Seoul, Korea
Internship   Samsung Medical Center, Seoul, Korea

Professional Memberships

A member of the Korean Cancer Association and the Korean Association for Clinical Oncology
A member of the American Society of Clinical Oncology and the European Society for Medical Oncology

Selected Publications

  • LANCET ONCOL 2021 10.1016/S1470-2045(21)00094-2 Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV-201): a multicentre, single-arm, phase 2 trial Yu1, EY; Petrylak, DP; O'Donnell, PH; Lee, JL; van der Heijden, MS; Loriot, Y; Stein, MN; Necchi, A; Kojima, T; Harrison, MR; Park, SH; Quinn, DI; Heath, EI; Rosenberg, JE; Steinberg, J; Liang, SY; Trowbridge, J; Campbell, M; McGregor, B; Balar, AV
    View PubMed
  • J PERS MED 2021 10.3390/jpm11060575 Detection of Aberrant Glycosylation of Serum Haptoglobin for Gastric Cancer Diagnosis Using a Middle-Up-Down Glycoproteome Platform Jeong1, S; Kim, U; Oh, M; Nam, J; Park, S; Choi, Y; Lee, D; Kim, J; An, H
    View PubMed
  • NEW ENGL J MED 2021 10.1056/NEJMoa2034442 Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma Bajorin1, DF; Witjes, JA; Gschwend, JE; Schenker, M; Valderrama, BP; Tomita, Y; Bamias, A; Lebret, T; Shariat, SF; Park, SH; Ye, D; Agerbaek, M; Enting, D; McDermott, R; Gajate, P; Peer, A; Milowsky, MI; Nosov, A; Antonio, JN; Tupikowski, K; Toms, L; Fischer, BS; Qureshi, A; Collette, S; Unsal-Kacmaz, K; Broughton, E; Zardavas, D; Koon, HB; Galsky, MD
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2020.213 2020 Korean guidelines for the management of metastatic prostate cancer Kim1, IH; Shin, SJ; Kang, BW; Kang, J; Kim, D; Kim, M; Kim, JY; Kim, CK; Kim, HJ; Maeng, CH; Park, K; Park, I; Bae, WK; Sohn, BS; Lee, MY; Lee, JL; Lee, J; Lim, ST; Lim, JH; Chang, H; Jung, JY; Choi, YJ; Kim, YS; Cho, J; Joung, JY; Park, SH; Lee, HJ
    View PubMed
  • ONCOLOGY-BASEL 2021 10.1159/000514404 Programmed Death Ligand 1 Expression as a Prognostic Marker in Patients with Advanced Biliary Tract Cancer Kim1, H; Kim, J; Byeon, S; Jang, KT; Hong, JY; Lee, JY; Park, SH; Park, JO; Park, YS; Lim, HY; Kang, WK; Kim, ST
    View PubMed